| Catalog | name | Description | price |
|---|---|---|---|
| R-C-2290 | NSC 207895 CAS:58131-57-0 | NSC207895 is a cell-permeable benzofuroxan compound that downregulates the p53 negative regulator MDMX protein level in MCF-7,LNCaP,and A549 cells(1 to 10µM for 16 to 24h)by suppressesing MDMX promoter transcription activity(IC50=2.5µM in HT1080 cells),leading to enhanced p53 stabilization and activation. | price> |
| R-C-2498 | Belnacasan (VX-765) CAS:273404-37-8 | Belnacasan(VX-765)is an orally bioactive prodrug of VRT-043198,which is a potent and selective inhibitor of IL-converting enzyme(ICE)/caspase-1 with Kis of 0.8nM and less than 0.6nM for caspase-1 and caspase-4,respectively.Belnacasan (VX-765)inhibits the release of LPS-induced IL-1β and IL-18 by human PBMCs with an IC50 of ~0.7μM. | price> |
| R-C-2565 | MDK83190 CAS:79183-19-0 | MDK83190 is a potent apoptosis activator,induces Apaf-1 oligomerization, increases procaspase-9 processing and subsequent caspase-3 activation in a cyto c-dependent Manner. | price> |
| R-C-2575 | Sabutoclax CAS:1228108-65-3 | Sabutoclax(BI-97C1)is a potent a Mcl-1 Antagonist.Sabutoclax inhibits Tumorigenesis in Transgenic Mouse and Human Xenograft Models of Prostate Cancer. Sabutoclax(BI97C1)induce mitochondrial fragmentation either upstream of or independent of apoptosis. | price> |
| R-C-2576 | NVP-CGM097 CAS:1313363-54-0 | NVP-CGM097 is a highly potent and selective MDM2 inhibitor with Ki value of 1.3nM for hMDM2 in TR-FRET assay.It binds to the p53 binding-site of the Mdm2 protein,disrupting the interaction between both proteins,leading to an activation of the p53 pathway. | price> |
| R-C-2577 | Navtemadlin (AMG 232) CAS:1352066-68-2 | Navtemadlin(AMG 232)is a potent,selective and orally available inhibitor of p53-MDM2 interaction,with an IC50 of 0.6nM.Navtemadlin binds to MDM2 with a Kd of 0.045nM. | price> |
| R-C-2579 | YH239-EE CAS:1364488-67-4 | YH239-EE,ethyl ester of the free carboxylic acid compound YH239,is a potent p53-MDM2 antagonizing and apoptosis-inducing agent. | price> |
| R-C-2580 | BM-1074 CAS:1391108-10-3 | BM-1074 is a potent Bcl-2/Bcl-xL inhibitor which is capable of achieving rapid, complete,and durable tumor regression in vivo. | price> |
| R-C-2582 | WEHI-539 CAS:1431866-33-9 | WEHI-539 was designed as a BCL-XLinhibitor with high affinity.It interacted the with the binding groove of BCL-XLwith a Kd value of 0.6nM.In MEF cells lacking MCL-1,WEHI-539 induced apoptosis which was evidenced by the release of mitochondrial cytochrome cand caspase-3 processing. | price> |
| R-C-2583 | SMIP004 CAS:143360-00-3 | SMIP004 is a novel inducer of cancer-cell selective apoptosis of human prostate cancer cells.SMIP004 decreased the levels of positive cell cycle regulators, upregulated cyclin-dependent kinase inhibitors,and resulted in G1 arrest, inhibition of colony formation in soft agar,and cell death. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


